DGAP-News: Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG
/ Key word(s): Preliminary Results
Berlin, 25 February 2020. The Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX), achieved sales of just under 180 million EUR and earnings per share of 4.29 EUR in fiscal year 2019 according to preliminary, unaudited calculations. Without the one-off effects forecasted on November 12, earnings per share would have amounted to around EUR 4.60. The complete and audited financial statements for 2019 and the forecast for 2020 will be published on 31 March 2020. About Eckert & Ziegler. Your contact:
25.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | +49 30 941084-138 |
Fax: | +49 30 941084-112 |
E-mail: | [email protected] |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 982981 |
End of News | DGAP News Service |
|
982981 25.02.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie
Die Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie erhält starke Unterstützung mit mehreren Buy- und keiner Sell-Einschätzung.
Das Kursziel von 95 € für Eckert & Ziegler Strahlen- und Medizintechnik AG impliziert eine deutliche Steigerung um über 50% gegenüber 48.12 €.